Studies have shown that, regardless of whether a therapy is based on monomeric components extracted from plants or classic drugs that have been clinically used in cancer treatment for many years, a therapy can inhibit ovarian cancer progression after directly or indirectly inhibiting HIF-1α. The gene discussed is HIF1A; the disease is cancer.